newsfilter
← Latest News
GlobeNewswire·

Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Anaphylm resubmission accepted with PDUFA goal date of March 16, 2027 Anaphylm would be the first and only oral rescue medication for the treatment of severe allergic reactions, including anaphylaxis, if